期刊文献+

同种异体胰岛及胰腺干细胞来源的胰岛样结构序贯移植治疗糖尿病 被引量:2

Transplantation of allogeneic pancreatic islets and pancreatic stem cells-derived islet-like structures to treat diabetes
原文传递
导出
摘要 目的观察同种异体大鼠胰岛及胰腺干细胞来源的胰岛样结构序贯移植在糖尿病治疗中的作用。方法分离胰腺组织获得胰岛及胰腺导管上皮细胞,将具有干细胞潜能的胰腺导管上皮细胞在体外培养27d。将新鲜分离的胰岛(200±50)个及诱导分化2周的胰腺干细胞来源的胰岛样结构(2×10^6)个序贯移植到糖尿病大鼠的肾被膜下观察大鼠的血糖及生存情况。结果将胰岛及胰腺干细胞来源的胰岛样结构序贯移植到同一糖尿病大鼠3周后血糖仍在5mmol/L水平,对照组血糖无明显下降。结论胰腺干细胞可诱导分化为分泌胰岛素的胰岛样结构,胰岛及胰腺干细胞来源的胰岛样结构序贯移植对大鼠糖尿病有治疗作用。 Objective To observe the transplantation of allogeneic pancreatic islets and pancreatic stem cells-derived islet-like structures in the treatment of diabetes. Methods The pancreatic tissue was isolated to obtain the islets and pancreatic duct epithelial cells. Pancreatic duct epithelial cells which have the potential of stem cells were cultivated in vitro for up to 27 days. The freshly isolated pancreatic islets (200 ± 50) and pancreatic stem cells-derived islet-like structures (2 × 10^6) collected 2 weeks after differentiation in vitro were transplanted under the kidney capsule of the same rats. Blood glucose level and the subsistence state were observed. Results Blood glucose level was 5 mmol/L in diabetic rats 3 weeks after the transplantation of freshly isolated allogeneic pancreatic islets and pancreatic stem cell-derived islet-like structures. In control group, the blood glucose level had significant decrease. Condusion Pancreatic stem cells can differentiate into islet-like structures in vitro. Pancreatic islets and pancreatic stem cells-derived islet-like structures have a potential application to cure diabetes.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2008年第9期1170-1172,F0004,共4页 Chinese Journal of Experimental Surgery
关键词 胰岛 胰腺干细胞 糖尿病 胰岛样结构 Pancreatic islets Pancreatic stem cells Diabetes mellitus Islet-llke Structures
  • 相关文献

参考文献8

二级参考文献18

  • 1Jonuleit H, Schmitt E, Schuler G, et al. Induction of interleukin 10-producing nonproliferating CD4 + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med, 2000, 192:1213-1222.
  • 2Tajima K, Amakawa R, Ito T, et al. Immunomodulatory effects of cyclosporin A on human peripheral blood dendritic cell subsets. Immunology, 2003, 108:321-328.
  • 3Kita Y, Li XK, Nogimura H, et al. Prolonged graft survival induced by CTLA4Ig gene transfection in rat lung allografting. Transplant Proc,2003, 35: 456-457.
  • 4Umeda Y, Iwata H, Yoshikawa S, et al. Gene gun-mediated CTLA4IgGene transfer for modification of allogeneic cardiac grafts. Transplant Proc, 2002, 34:2622-2623.
  • 5Shindo J. Effect of CTLA4Ig gene transfer with adenovirus vector on allogeneic renal graft survival in the rat. Hokkaido Igaku Zasshi, 2001,76:251-261.
  • 6Lu L, Gambotto A, Lee WC, et al. Adenoviral delivery of CTLA4Ig into myeloid dendritic cells promotes their in vitro tolerogenicity and survival in allogeneic recipients. Gene Ther, 1999, 6:554-563.
  • 7Miao G, Ito T, Uchikoshi F, et al. Development of donor-specific immunoregulatory T- cells after local CTLA4Ig gene transfer to pancreatic allograft. Trannsllantation, 2004, 78: 59-64.
  • 8Naheyama K, Yasunami Y, Toyofuku A, et al. Beneficial effects of costimulatory blockade with anti-inducible costimulator antibody in conjunction with CTLA4Ig on prevention of islet xenograft rejection from rat to mouse, Transplantation, 2004, 78:1590-1596.
  • 9Robert WO, Sang K, Jennifer A, et al. A dendritic cell line genetically modified to express CTLA4Ig as a means to prolong islet allograft survival. Tranplantation, 2000, 69:1440-1446.
  • 10Alfred A, Chahine GS, Ming YU, et al. Immunomodulation of pancreatic islet allografts in mice with CTLA4Ig secreting muscle cells. Tranplantation, 1995, 59:1313-1318.

共引文献19

同被引文献20

  • 1Kayali AG, Flores LE, Lopez AD, et al. Limited capacity of human adult islets expanded in vitro to redifferentiate into insulin-preducing beta-cells. Diabetes, 2007,56:703-708.
  • 2Ianus A, Holz GG, Theise ND, et al. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest,2003,111:843-850.
  • 3Gao X, Song L, Shen K, et al. Transplantation of bone marrow derived cells promotes pancreatic islet repair in diabetic mice. Biochem Biophys Res Commun,2008,371 : 132-137.
  • 4Choi KS,Shin JS,Lee JJ,et al. In vitro trans-differentiation of rat mesenchymal cells into insulin-producing cells by rat pancreatic extract. Biochem Biophys Res Commun,2005,330 : 1299 -305.
  • 5Smith RM, Mandel TE. Pancreatic islet xenotransplantation:the potential for tolerance induction. Immunol Today,2000,21:42-48.
  • 6Mattsson G, Jansson L, Carlsson PO. Decreased vascular density in mouse pancreatic islets after transplantation. Diabetes, 2002, 51: 1362-1366.
  • 7Konno S, Takebayashi Y, Aiba M, et al. Clinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinoma. Cancer Lett, 2001,166: 103- 111.
  • 8DeLisser HM, Christofidou-Solomidou M, Strieter RM, et al. Involvement of endothelial PECAM-1/CD31 in angiogenesis. Am J Pathol, 1997.151:671-677.
  • 9Kodama S, Kuhtreiber W, Fujimura S, et al. Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science, 2003, 302 : 1223-1227.
  • 10Shapiro AM,Ricordi C,Hering BJ,et al.International trial of the Edmonton protocol for islet transplantation.N Engl J Med,2006,355:1318-1330.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部